Bank of Montreal
TXMD icon

Bank of Montreal’s TherapeuticsMD TXMD Stock Holding History

Bank of Montreal’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-8,902
Closed -$632K – 5351
2020
Q4 		$632K Hold
8,902
– – ﹤0.01% 2569
2020
Q3 		$712K Buy
+8,902
New +$710K ﹤0.01% 2146
2020
Q1 		– Sell
-2,328
Closed -$282K – 4718
2019
Q4 		$282K Sell
2,328
-3,098
-57% -$445K ﹤0.01% 2977
2019
Q3 		$985K Buy
5,426
+3,146
+138% +$443K ﹤0.01% 2086
2019
Q2 		$296K Buy
+2,280
New +$409K ﹤0.01% 2716
2018
Q3 		– Sell
-120
Closed -$37K – 4892
2018
Q2 		$37K Sell
120
-80
-40% -$24.4K ﹤0.01% 3538
2018
Q1 		$49K Buy
+200
New +$56.1K ﹤0.01% 3236

Other funds holding TXMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bank of Montreal's TXMD Position: Q2 2021 in Review

Bank of Montreal sold out of TherapeuticsMD (TXMD) in Q2 2021, closing a stake of 200 shares — an estimated $13K sold.

Bank of Montreal first reported a position in TXMD in Q2 2014 and held it in 24 quarters. The position peaked at $1.32M in Q3 2019. 154 funds tracked by Wall St. Rank hold TXMD as of Q2 2021.

  • Bank of Montreal reported no remaining TherapeuticsMD position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 200 TherapeuticsMD shares in Q2 2021, an estimated $13K.
  • Bank of Montreal first reported a position in TherapeuticsMD in Q2 2014 and held it in 24 quarters.
  • Bank of Montreal's TherapeuticsMD position peaked at $1.32M in Q3 2019.
  • 154 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.